αvβ3 Integrin-mediated adenoviral transfer of interleukin-12 at the periphery of hepatic colon cancer metastases induces VCAM-1 expression and T-cell recruitment

Molecular Therapy

Volumn 3, Issue 5, 2001, Pages 665-672

  Mazzolini, Guillermo ^a   Narvaiza, Iñigo ^a   Bustos, Matilde ^a   Duarte, Marina ^a   Tirapu, Iñigo ^a   Bilbao, Roberto ^a   Qian, Cheng ^a   Prieto, Jesús ^a   Melero, Ignacio ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

Author keywords

Adenovirus; Adoptive T cell therapy; Colon cancer; Gene therapy; Immunotherapy; Interleukin 12; VCAM 1 (CD106); v 3 (CD51 CD61)

Indexed keywords

BETA3 INTEGRIN; INTERLEUKIN 12; VASCULAR CELL ADHESION MOLECULE 1; VIRUS VECTOR;

ADENOVIRUS; ADOPTIVE TRANSFER; ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER IMMUNOTHERAPY; COLON CANCER; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; GENE EXPRESSION; GENE INDUCTION; GENE LOCATION; GENE THERAPY; GENE TRANSFER; GENETIC CODE; HUMAN; HUMAN CELL; LIVER METASTASIS; MOUSE; NONHUMAN; SUBCUTANEOUS NODULE; TRANSGENE; VIRUS RECOMBINANT;

ADENOVIRIDAE; ANIMALIA;

EID: 0034980715     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1006/mthe.2001.0317     Document Type: Article

References (44)

1. Adenovirus vectors for high-efficiency gene transfer into mammalian cells
2. Adenovirus-mediated interleukin-12 gene therapy for metastatic colon carcinoma
3. Direct intratumoral injection of an adenovirus expressing interleukin-12 induces regression and long-lasting immunity that is associated with highly localized expression of interleukin-12
4. Induction of antitumor immunity by direct intratumoral injection of a recombinant adenovirus vector expressing interleukin-12
5. Regression of colon cancer and induction of antitumor immunity by intratumoral injection of adenovirus expressing interleukin-12
6. Anti-tumor immunity induced by in vivo adenovirus vector-mediated expression of CD40 ligand in tumor cells
7. In vivo gene transfer of CD40 ligand into colon cancer cells induces local production of cytokines and chemokines, tumor eradication and protective antitumor immunity
8. Intratumoral coinjection of adenoviral vectors expressing IL-2 and IL-12 results in enhanced frequency of regression of injected and untreated distal tumors
9. Adenoviral vectors expressing lymphotactin and interleukin 2 or lymphotactin and interleukin 12 synergize to facilitate tumor regression in murine breast cancer models
10. Genetic immunotherapy of established tumors with adenovirus-murine granulocyte-macrophage colony-stimulating factor
11. Replicative adenoviruses for cancer therapy
12. Cell receptors involved in adenovirus entry
13. Role of alpha(v) integrins in adenovirus cell entry and gene delivery
14. The role of alphav integrins during angiogenesis: Insights into potential mechanisms of action and clinical development
15. Detection of tumor angiogenesis in vivo by alphaVbeta3-targeted magnetic resonance imaging
16. Targeted antiangiogenic therapy for cancer using Vitaxin: A humanized monoclonal antibody to the integrin
17. Synergy between an antiangiogenic integrin alphav antagonist and an antibody-cytokine fusion protein eradicates spontaneous tumor metastases
18. Intratumoral coinjection of two adenoviruses, one encoding the chemokine IFN-gamma-inducible protein-10 and another encoding IL-12, results in marked antitumoral synergy
19. Interleukin 12 and B7-1 costimulatory molecule expressed by an adenovirus vector act synergistically to facilitate tumor regression
20. Immunomodulatory gene therapy with interleukin 12 and 4-1BB ligand: Long-term remission of liver metastases in a mouse model
21. Rejection of disseminated metastases of colon carcinoma by synergism of IL-12 gene therapy and 4-1BB costimulation
22. Role of NK and T cells in IL-12-induced anti-tumor response against hepatic colon carcinoma
23. Adenoviral gene transfer of interleukin 12 into tumors synergizes with adoptive T cell therapy both at the induction and effector level
24. Adenovirus-mediated expression of interleukin-12 induces natural killer cell activity and complements adenovirus-directed gp75 treatment of melanoma lung metastases
25. Inhibition of angiogenesis in vivo by interleukin
26. Inhibition of angiogenesis by interleukin-12 is mediated by the interferon-inducible protein 10
27. A critical role for a peritumoral stromal reaction in the induction of T-cell migration responsible for interleukin-12-induced tumor regression
28. Multiple roles of interferon-gamma in the mediation of interleukin 12-induced tumor regression
29. Interferon enhances tumor necrosis factor-induced vascular cell adhesion molecule 1 (CD106) expression in human endothelial cells by an interferon-related factor 1-dependent pathway
30. The leukocyte beta 1 integrins
31. Multiple activation states of integrin alpha4beta1 detected through their different affinities for a small molecule ligand
32. Functional relevance during lymphocyte migration and cellular localization of activated beta1 integrins
33. Isolation and characterization of an established endothelial cell line from transgenic mouse hemangiomas
34. Immunological ignorance of an E7-encoded cytolytic T-lymphocyte epitope in transgenic mice expressing the E7 and E6 oncogenes of human papillomavirus type 16
35. Expression and function of alpha 4/beta 7 integrin on human natural killer cells
36. IL-12-induced tumor regression correlates with in situ activity of IFN-gamma produced by tumor-infiltrating cells and its secondary induction of anti-tumor pathways
37. Eradication of established tumors by CD8+ T cell adoptive immunotherapy
38. Prospects for adoptive T cell therapy
39. Costimulation of T cells for tumor immunity
40. Differential requirements for alpha4 integrins during fetal and adult hematopoiesis
41. Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo
42. A role for the interferon-inducible protein 10 in inhibition of angiogenesis by interleukin-12
43. Contribution of the CXC chemokines IP-10 and Mig to the antitumor effects of IL-12
44. Gene therapy of orthotopic hepatocellular carcinoma in rats using adenovirus coding for interleukin-12